|
NHSL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.91828799908944E-14 |
| Normal-vs-Stage2 |
1.14049999999644E-06 |
| Normal-vs-Stage3 |
3.91860000004129E-07 |
| Normal-vs-Stage4 |
8.649900E-04 |
| Stage1-vs-Stage2 |
7.102800E-01 |
| Stage1-vs-Stage3 |
2.892200E-01 |
| Stage1-vs-Stage4 |
9.229000E-01 |
| Stage2-vs-Stage3 |
6.069800E-01 |
| Stage2-vs-Stage4 |
7.605200E-01 |
| Stage3-vs-Stage4 |
4.904600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63469238145808E-12 |
| Normal-vs-AfricanAmerican |
1.221560E-03 |
| Normal-vs-Asian |
2.34739999999123E-05 |
| Caucasian-vs-AfricanAmerican |
9.298000E-01 |
| Caucasian-vs-Asian |
2.501000E-01 |
| AfricanAmerican-vs-Asian |
5.268600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20459975327947E-10 |
| Normal-vs-Female |
6.0285110237146E-14 |
| Male-vs-Female |
7.435400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52433621281034E-12 |
| Normal-vs-Age(41-60Yrs) |
1.67659996996861E-09 |
| Normal-vs-Age(61-80Yrs) |
1.54969999999199E-05 |
| Normal-vs-Age(81-100Yrs) |
1.350400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.624500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.612780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.843400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.474400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.005200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.851000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.481800E-01 |
| Classical-VS-Follicular |
8.376300E-04 |
| Classical-VS-Other |
1.167640E-01 |
| Classical-VS-Normal |
2.22044604925031E-16 |
| Tall-VS-Follicular |
9.496400E-02 |
| Tall-VS-Other |
1.097210E-01 |
| Tall-VS-Normal |
2.380100E-04 |
| Follicular-VS-Other |
3.011600E-01 |
| Follicular-VS-Normal |
3.84310000000054E-05 |
| Other-VS-Normal |
4.463000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67770036646675E-10 |
| Normal-vs-N1 |
1.400590E-04 |
| N0-vs-N1 |
3.153000E-01 |
|
|
